Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

• Market Cap: HK$127.38M
• Dividend Yield: N/A
• Average Volume (3M): 1.60M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.01
• Revenue Growth: -56.16%
• EPS Growth: 62.50%
• Country: HK
• Employees: 118
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Care Facilities
• EPS (TTM): 0.01
• Shares Outstanding: 1,127,299,900
• 10 Day Avg. Volume: 4,552,093
• 30 Day Avg. Volume: 1,601,290
• PEG Ratio: -0.24
• Price to Book (P/B): 3.59
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: ―

The overall score reflects significant financial challenges, including declining revenue and profitability issues. Despite upward momentum in technical analysis, the stock appears overbought, increasing the risk of a correction. The valuation is weak due to a negative P/E ratio and lack of dividends.

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company Description

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.

How the Company Makes Money

Good Fellow Healthcare Holdings Limited generates revenue through multiple streams within the healthcare sector. This includes income from medical services provided at its facilities, sales of healthcare-related products, and possibly collaborations with other healthcare entities. The company may also benefit from government healthcare programs or private partnerships that contribute to its financial stability. The diversification within the healthcare services and product offerings helps in maintaining a steady flow of income.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary

Good Fellow Healthcare Holdings Limited is facing significant financial challenges, as evidenced by declining revenues, persistent net losses, and a weakening balance sheet. The company is under pressure with high leverage and cash flow constraints, suggesting a need for strategic restructuring to improve financial health and performance.

Income Statement

The company has experienced a significant decline in revenue over the past few years, with a revenue decrease from $144.59 million in 2020 to $38.96 million in 2024. Gross profit margin has also deteriorated, alongside negative EBIT and net profit margins, indicating operational challenges. The continued negative net income suggests persistent profitability issues.

Balance Sheet

The balance sheet shows a high leverage with a debt-to-equity ratio increasing due to rising total liabilities and decreased equity. The equity ratio has decreased significantly over the years, indicating higher financial risk. Stockholders' equity has been notably reduced from 2020 to 2024, reflecting financial instability.

Cash Flow

The company's cash flow statements reveal a volatile and declining cash flow position. Negative free cash flow and operating cash flow over the recent years highlight liquidity issues. Although there was a positive operating cash flow in 2021, overall cash flow management remains a concern due to substantial negative free cash flow.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
23.27M	38.96M	55.35M	54.24M	53.89M	144.59M
	Gross Profit
7.46M	18.67M	27.01M	26.66M	26.45M	61.00M
	EBIT
597.50K	-16.04M	-5.24M	-5.89M	-37.05M	-48.58M
	EBITDA
-4.41M	-10.12M	1.83M	4.38M	-23.55M	-22.43M
	Net Income Common Stockholders
-2.35M	-17.11M	-5.88M	-12.69M	-30.18M	-49.50M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
91.04M	3.88M	18.36M	25.15M	44.89M	56.16M
	Total Assets
1.37B	29.15M	41.70M	60.45M	191.38M	183.17M
	Total Debt
247.35M	12.23M	4.49M	7.36M	29.73M	21.19M
	Net Debt
170.12M	8.59M	-13.19M	-9.43M	-8.34M	-34.25M
	Total Liabilities
498.02M	27.74M	22.32M	34.08M	158.48M	111.40M
	Stockholders Equity
836.99M	4.36M	22.19M	29.59M	40.23M	77.42M
Cash Flow		Free Cash Flow
-15.78M	-15.35M	-3.84M	-24.51M	-21.21M	-52.13M
	Operating Cash Flow
-1.29M	-854.00K	-1.32M	-22.93M	1.25M	35.36M
	Investing Cash Flow
-1.68M	-14.46M	5.74M	2.19M	-24.28M	-82.79M
	Financing Cash Flow
2.39M	4.36M	-2.75M	-5.61M	4.83M	-23.33M

Good Fellow Healthcare Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.13
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 55.28 is Neutral, neither overbought nor oversold. The STOCH value of 21.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	54 Neutral	$5.37B	3.35	-45.10%	2.79%	16.77%	-0.01%
8143	51 Neutral	HK$127.38M	―	-18.22%	―	-56.16%	62.50%
PIAIF		$124.52B	6.11		5.94%	―	―
CCGDF		$5.45B	24.76	1.57%	4.80%	―	―
PANHF		$1.88B	87.77	0.96%	―	―	―
6093	68 Neutral	HK$750.40M	12.73	7.83%	―	1.96%	-32.15%
3869	48 Neutral	HK$594.23M	―	-10.78%	―	-0.95%	-128.35%